Related references
Note: Only part of the references are listed.Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix
A. Klepfish et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inhibition of Platelet GPIbα and Promotion of Melanoma Metastasis
Luise Erpenbeck et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
Gareth O. Griffiths et al.
BMC CANCER (2009)
Platelets: Guardians of Tumor Vasculature
Benoit Ho-Tin-Noe et al.
CANCER RESEARCH (2009)
Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
Hans-Georg Kopp et al.
CANCER RESEARCH (2009)
Platelet granule secretion continuously prevents intratumor hemorrhage
Benoit Ho-Tin-Noe et al.
CANCER RESEARCH (2008)
Heparin as an anticancer therapeutic
Leo R. Zacharski et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
APT102, a novel ADPase, cooperates with aspirin to disrupt bone metastasis in mice
Oezge Uluckan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase
Christopher L. Hall et al.
NEOPLASIA (2008)
Adhesion mechanisms in platelet function
Zaverio M. Ruggeri et al.
CIRCULATION RESEARCH (2007)
Platelet glycoprotein Ibα supports experimental lung metastasis
Shashank Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Ajit Varki
NATURE (2007)
Role of von Willebrand factor in tumor metastasis
Virginie Terraube et al.
THROMBOSIS RESEARCH (2007)
Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects
Jennifer L. Stevenson et al.
THROMBOSIS RESEARCH (2007)
Clinical Studies with Anticoagulants to Improve Survival in Cancer Patients
Grigoris T. Gerotziafas et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma
Ali Ayhan et al.
GYNECOLOGIC ONCOLOGY (2006)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Selectins - potential pharmacological targets?
Carsten Kneuer et al.
DRUG DISCOVERY TODAY (2006)
Nucleotide receptor signaling in platelets
B. N. Kahner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Low-molecular-weight heparin in patients with advanced cancer: A phase 3 clinical trial
Kostandinos Sideras et al.
MAYO CLINIC PROCEEDINGS (2006)
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice
V Terraube et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism
Simon Lockyer et al.
THROMBOSIS RESEARCH (2006)
Differential metastasis inhibition by clinically relevant levels of heparins - Correlation with selectin inhibition, not antithrombotic activity
JL Stevenson et al.
CLINICAL CANCER RESEARCH (2005)
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis
RJ Ludwig et al.
CANCER RESEARCH (2004)
The role of collagen in thrombosis and hemostasis
RW Farndale et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Central role of the P2Y12 receptor in platelet activation
RT Dorsam et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Integrins: dynamic scaffolds for adhesion and signaling in platelets
SJ Shattil et al.
BLOOD (2004)
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
M Altinbas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
E Camerer et al.
BLOOD (2004)
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation
JH Im et al.
CANCER RESEARCH (2004)
Signalling through the platelet glycoprotein Ib-V-IX complex
H Canobbio et al.
CELLULAR SIGNALLING (2004)
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins
D Alonso-Escolano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Genetic deletion of mouse platelet glycoprotein Ibβ produces a Bernard-Soulier phenotype with increased α-granule size
K Kato et al.
BLOOD (2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma
H Shimada et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Glycoprotein Ib-IX-V
RK Andrews et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Platelet-collagen interaction: is GPVI the central receptor?
B Nieswandt et al.
BLOOD (2003)
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
S Falati et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome
T Kanaji et al.
BLOOD (2002)
Absence of GPIbα is responsible for aberrant membrane development during megakaryocyte maturation:: Ultrastructural study using a transgenic model
CR Poujol et al.
EXPERIMENTAL HEMATOLOGY (2002)
Poor prognosis associated with thrombocytosis in patients with gastric cancer
M Ikeda et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
L Borsig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular basis for the relationship between thrombosis and cancer
FR Rickles et al.
THROMBOSIS RESEARCH (2001)
Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen
B Nieswandt et al.
EMBO JOURNAL (2001)
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
L Borsig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)
DI Simon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
